VACCINE USAGE: RECOMBIVAX HB is a vaccine indicated for prevention of infection caused by all known subtypes of hepatitis B virus. RECOMBIVAX HB is approved for use in individuals of all ages.
RECOMBIVAX HB DIALYSIS FORMULATION is approved for use in predialysis and dialysis patients 18 years of age and older.
- Persons from birth through 19 years of age: A series of 3 doses (0.5 mL each) given on a 0-, 1-, and 6-month schedule.
- Adolescents 11 through 15 years of age: A series of either 3 doses (0.5 mL each) given on a 0-, 1-, and 6-month schedule or a series of 2 doses (1.0 mL) on a 0- and 4- to 6-month schedule).
- Persons 20 years of age and older: A series of 3 doses (1.0 mL each) given on a 0-, 1-, and 6-month schedule.
RECOMBIVAX HB DIALYSIS FORMULATION:<
- Adults on predialysis or dialysis: A series of 3 doses (1.0 mL each) given on a 0-, 1-, and 6-month schedule.
VACCINE INGEDIENTS: yeast protein, soy peptone, dextrose, amino acids, mineral salts, potassium aluminum sulfate, amorphous aluminum hydroxyphosphate sulfate, formaldehyde.
ADVERSE VACCINE REACTIONS: fatigue, weakness, high fever, nausea, diarrhea, pharyngitis, upper respiratory infection, sweating, chills, diminished appetite, rhinitis, influenza, cough, vertigo/ dizziness, paresthesia, pruritus, rash, angioedema, myalgia, back pain, lymphadenopathy, insomnia, earaches, dysuria, hypotension, elevation of liver enzymes, constipation, Guillain- Barre syndrome, multiple sclerosis, seizures, febrile seizures, herpes zoster, encephalitis, eczema, arthritis, extreme pain, lupus-like syndrome.